Skip to main content
Log in

Functional dynamic MRI, pharmacokinetics and safety of Gd-DTPA in patients with impaired renal function

  • Original articles
  • Magnetic resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Renal elimination of the paramagnetic contrast agent Gadolinium-DTPA (Gd-DTPA) was analyzed in 24 patients with impaired renal function and 3 normal controls. Dynamic magnetic resonance studies were performed using fast gradient-echo sequences with single images during suspended respiration and a temporal resolution of 10s per image. The time between appearance of the contrast agent in the renal cortex and signal intensity drop mL/min the medulla, due to a high concentration of Gd-DTPA and predominant T2-shortening, was an indicator of glomerular filtration rate and correlated well with creatinine clearance values (r=0.81). Fractionate urine collections and serum analysis up to 120h following administration showed a prolonged but complete elimination of Gd-DTPA mL/min patients with creatinine clearance above 20 mL/min. Renal functional parameters did not change after administration of Gd-DTPA and no nephrotoxic effects were observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pettigrew RI, Avruch L, Dannels W, Coumans J, Bernardino WE (1986) Fast-field-echo MR imaging with Gd-DTPA: Physiologic evaluation of the kidney and liver. Radiology 160: 561–563

    Google Scholar 

  2. Kikinis R, von Schulthess GK, Jäger P, Dürr R, Bino M, Kuoni W, Kübler O (1987) Normal and hydronephrotic kidney: Evaluation of renal function with contrast-enhanced MR imaging. Radiology 165: 837–842

    Google Scholar 

  3. Carvlin MJ, Arger PH, Kundel HL, Axel L, Dougherty L, Kassab EA, Moore B (1987) Acute tubular necrosis: Use of Gadolinium-DTPA and fast MR imaging to evaluate renal function mL/min the rabbit. J Comput Assist Tomogr 11: 488–495

    Google Scholar 

  4. Gerig G, Wüthrich R, von Schulthess GK, Kikinis R, Kübler O (1987) Computer assisted ROI analysis of 1.5 T, MRI renal function studies with gradient echo sequences and Gd-DTPA. 6. Annual Meeting SMRM, New York, 20–25

    Google Scholar 

  5. Krestin GP, Friedmann G, Steinbrich W, Linden A (1988) Gd-DTPA enhanced fast dynamic MRI of kidneys and adrenals. Diagn Imaging Int, Suppl 4: 40–44

    Google Scholar 

  6. Krestin GP, Neufang KFR, Friedmann G, Clauss W, Shuhmann-Giampieri G, Stöckl B (1989) Functional dynamic MR imaging and pharmacokinetics of Gd-DTPA in patients with renal failure Radiology 173 (P): 269

    Google Scholar 

  7. Choyke PL, Frank JA, Girton MA, Inscoe SW, Carvlin MJ, Black JL, Austin HW, Dwyer AJ (1989) Dynamic Gadolinium-DTPA enhanced MRI of the kidneys: experimental results. Radiology 170: 713–720

    Google Scholar 

  8. Carvlin MJ, Arger PH, Kundel HL, Axel L, Dougherty L, Kassab EA, Moore B (1989) Use of Gd-DTPA and fast gradientecho and spin-echo MR imaging to demonstrate renal function in the rabbit. Radiology 170: 705–711

    Google Scholar 

  9. Frank JA, Choyke PL, Girton ME (1989) Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity. J Comput Assist Tomogr 13: 448–459

    Google Scholar 

  10. Krestin GP (1990) Morphologic and function MR of the kidneys and adrenal glands. Field and Wood, Philadelphia

    Google Scholar 

  11. Semelka RC, Hricak H, Tomei E, Floth A, Stoller M (1990) Obstructive nephropathy: evaluation with dynamic Gd-DTPA-enhanced MR imaging. Radiology 175: 797–803

    Google Scholar 

  12. Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of Gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142: 619–624

    Google Scholar 

  13. Haustein J, Niendorf H-P, Louton T, (1990) Tolerance of GdDTPA in 1171 patients. Radiology 177 (P): 167

    Google Scholar 

  14. Jamison R, Kritz W (1982) Urinary concentrating mechanism. Oxford University Press, London

    Google Scholar 

  15. Weinmann HJ, Laniado M, Mützel W (1984) Pharmacokinetics of gadolinium DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16: 167–172

    Google Scholar 

  16. Eilenberg SS, Lee JKT, Brown JJ, Mirowitz SA, Tartar VM (1990) Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Radiology 176: 333–338

    Google Scholar 

  17. Schuhmann-Giampieri G, Krestin GP (1991) Pharmacokinetics of dimeglumine gadopentetate in patients with impaired renal function. Invest Radiol 26: 975–979

    Google Scholar 

  18. Haustein J, Niendorf HP, Krestin GP, Louton T, Schuhmann-Giampieri G, Clauss W, Junge W (1991) Safety of Gd-DTPA in patients with impaired renal function and renal failure. Invest Radiol, in press

  19. Haustein J, Schuhmann-Giampieri G (1990) Elimination of Gd-DTPA by means of hemodialysis. Europ J Radiol 11: 227–229

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krestin, G.P., Schuhmann-Giampieri, G., Haustein, J. et al. Functional dynamic MRI, pharmacokinetics and safety of Gd-DTPA in patients with impaired renal function. Eur. Radiol. 2, 16–23 (1992). https://doi.org/10.1007/BF00714176

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00714176

Key words

Navigation